首页> 外文期刊>Circulation. Cardiovascular interventions >Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds Implications for Manufacturers and Next Device Iterations
【24h】

Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds Implications for Manufacturers and Next Device Iterations

机译:决策分析马尔可夫模型加权预期的效益和当前局限性对制造商和下一个设备迭代的第一代生物血管脚手架的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background-Relative benefits of bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents (EES) are expected to accrue after complete bioresorption.
机译:与完全生物化后,预期生物吸收血管支架(BVS)的背景相对益处(BVS)。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号